Boosting Tofacitinib Recruitment to the BCRD Study: Why Your Centre’s Participation Matters More Than Ever

by Katy Mowbray | Mar 19, 2026 | Uncategorised

BCRD/BSPAR ETN Boosting Tofacitinib Recruitment to the BCRD Study: Why Your Centre’s Participation Matters More Than Ever Across the UK, more children and young people with Juvenile Idiopathic Arthritis (JIA) are now starting tofacitinib. Although...

Research Results: Do children with JIA from different ethnic groups have different disease activity after treatment with methotrexate?

by Katy Mowbray | Feb 2, 2026 | Uncategorised

BCRD/BSPAR ETN Research Results: Do children with JIA from different ethnic groups have different disease activity after treatment with methotrexate?   The association between ethnicity, socioeconomic position and outcomes following initiation of methotrexate in...

Research Results: Improving Eye Screening for Children with Arthritis by Adding Genetic Insights

by Katy Mowbray | Jan 20, 2026 | Uncategorised

BCRD/BSPAR ETN Research Results: Improving Eye Screening for Children with Arthritis by Adding Genetic Insights Dr John Bowes explains his recent research from the CLUSTER consortium (which includes UK JIA Biologics Register data) looking at genetic markers predicting...

Collaboration with international JIA Registries

by Katy Mowbray | Dec 2, 2025 | Uncategorised

BCRD/BSPAR ETN Collaboration with international JIA Registries We asked UK JIA Biologics Register Co-Investigator Dr Lianne Kearsley Fleet to discuss her research: Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a...

Research Results: Machine-learning and JIA

by Katy Mowbray | Nov 13, 2025 | Uncategorised

BCRD/BSPAR ETN Research Results: Machine-learning and JIA Research Results: Machine-learning and JIA  Dr Stephanie Shoop-Worrall discusses her latest research from the CLUSTER consortium (which includes data from the UK JIA Biologics Register). This research looks at...